CNSX:VPVodis Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Vodis Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.04 0.00 (0.00 %) (As of 06/3/2020 02:38 AM ET) Add Compare Share Today's Range$0.05Now: $0.05▼$0.0550-Day Range$0.03MA: $0.03▼$0.0552-Week Range$0.16Now: $0.05▼$0.62Volume40,000 shsAverage Volume1,714 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines Vodis Pharmaceuticals Inc. operates as an application stage company for producing medical marijuana. It operates in Canada and the United States. The company is based in Delta, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Vodis Pharmaceuticals. Previous Next 2.8 Community Rank Outperform VotesVodis Pharmaceuticals has received 28 “outperform” votes. (Add your “outperform” vote.)Underperform VotesVodis Pharmaceuticals has received 22 “underperform” votes. (Add your “underperform” vote.)Community SentimentVodis Pharmaceuticals has received 56.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Vodis Pharmaceuticals and other stocks. Vote “Outperform” if you believe VP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VP will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldVodis Pharmaceuticals does not currently pay a dividend.Dividend GrowthVodis Pharmaceuticals does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Vodis Pharmaceuticals insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.56 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCNSX:VP Previous Symbol CUSIPN/A CIKN/A Webvodis.ca Phone778-990-8985Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable TSXV:VP Rates by TradingView Receive VP News and Ratings via Email Sign-up to receive the latest news and ratings for VP and its competitors with MarketBeat's FREE daily newsletter. Vodis Pharmaceuticals (CNSX:VP) Frequently Asked Questions Has Vodis Pharmaceuticals been receiving favorable news coverage? News coverage about VP stock has been trending negative this week, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Vodis Pharmaceuticals earned a daily sentiment score of -2.8 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next few days. View the latest news aboutVodis Pharmaceuticals. Who are some of Vodis Pharmaceuticals' key competitors? Some companies that are related to Vodis Pharmaceuticals include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Admedus (AHZ), Almirall (LBTSF), Amarantus Bioscience (AMBS), Antibe Therapeutics (VBIZF), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Baudax Bio (BXRXV), BerGenBio ASA (BRRGF), Biocure Technology (CURE), Canada House Wellness Group (CHV) and Cannabics Pharmaceuticals (CNBX). View all competitors. What other stocks do shareholders of Vodis Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vodis Pharmaceuticals investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE), Apellis Pharmaceuticals (APLS), Aquantia (AQ) and Aquinox Pharmaceuticals (AQXP). Who are Vodis Pharmaceuticals' key executives? Vodis Pharmaceuticals' management team includes the following people: Mr. Brian R. Gusko, Advisor (Age 52)Mr. Mark Lotz B.B.A., C.A., CPA, Interim CEO, CFO & Director What is Vodis Pharmaceuticals' stock symbol? Vodis Pharmaceuticals trades on the CNSX under the ticker symbol "VP." How do I buy shares of Vodis Pharmaceuticals? Shares of VP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Vodis Pharmaceuticals' stock price today? One share of VP stock can currently be purchased for approximately $0.05. What is Vodis Pharmaceuticals' official website? The official website for Vodis Pharmaceuticals is vodis.ca. How can I contact Vodis Pharmaceuticals? The company can be reached via phone at 778-990-8985. This page was last updated on 6/3/2020 by MarketBeat.com Staff
